humanized mAbs/antibody fragments (PharmAbs)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehumanized mAbs/antibody fragments (PharmAbs)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPharmAbs

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPharmAbs

Active IndicationsN/A

Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A